BRIEF published on 11/05/2025 at 18:01, 29 days 16 hours ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 29 days 16 hours ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 3 months 24 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
BRIEF published on 08/12/2025 at 07:05, 3 months 24 days ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
PRESS RELEASE published on 08/12/2025 at 07:00, 3 months 24 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 4 months ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 10:00, 4 months ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 09:58, 4 months ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
BRIEF published on 08/05/2025 at 09:58, 4 months ago SCHOTT Pharma met à jour ses prévisions de chiffre d'affaires et d'EBITDA pour l'exercice 2025 Résultats Financiers SCHOTT Pharma Marge EBITDA Croissance Des Revenus Orientations Pour L'exercice 2025
PRESS RELEASE published on 08/05/2025 at 09:55, 4 months ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
Published on 12/05/2025 at 02:35, 7 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 36 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 46 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 11 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 16 minutes ago Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 08:45, 1 hour 31 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 31 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 34 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 2 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 16 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
